Molecular classification of cutaneous malignant melanoma by gene expression profiling

Nature

Volumn 406, Issue 6795, 2000, Pages 536-540

  Bittner, M ^a   Meltzer, P ^a   Chen, Y ^a   Jiang, Y ^a   Seftor, E ^c   Hendrix, M ^c   Radmacher, M ^d   Simon, R ^d   Yakhini, Z ^e   Ben Dor, A ^e,f   Sampas, N ^e   Dougherty, E ^h   Wang, E ^d   Marincola, F ^d   Gooden, C ^a   Lueders, J ^a   Glatfelter, A ^a   Pollock, P ^g   Carpten, J ^a   Gillanders, E ^a   Leja, D ^a   Dietrich, K ^a   Beaudry, C ^b   Berens, M ^b   Alberts, D ⁱ   Sondak, V ^j   Hayward, N ^g   Trent, J ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AGILENT LABORATORIES   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^h TEXAS A AND M UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ARIZONA   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER CLASSIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL;

ADULT; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0034601455     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35020115     Document Type: Article

References (30)

1. Hall, H. I., Miller, D. R., Rogers, J. D. & Bewerse, B. Update on the incidence and mortality from melanoma in the United States. J. Am. Acad. Dermatol. 40, 35-42 (1999).
2. Weyers, W., Euler, M., Diaz-Cascajo, C., Schill, W. B. & Banczkowitz, M. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer 86, 288-299 (1999).
3. Byers, H. R. & Bhawan, J. Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma. Hematol. Oncol. Clin. North Am. 12, 717-735 (1998).
4. McMasters, K. M., Sondak, V. K., Lotze, M. T. & Ross, M. I. Recent advances in melanoma staging and therapy. Ann. Surg. Oncol. 6, 467-475, (1999).
5. Maniotis, A. J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155, 739-752 (1999).
6. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
7. Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009-5013 (1998)
8. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999).
9. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537, (1999).
10. Alizadeh, A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
11. Bittner, M., Meltzer P. & Trent J. Data analysis and integration: of steps and arrows. Nature Genet. 22, 213-215 (1999).
12. Eisen, M. B., Spellman, P. T., Brown P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
13. Everitt, B. Applied Multivariate Data Analysis. (Oxford Univ. Press, New York, 1992)
14. Ben-Dor, A., Shamir, R. & Yakhini, Z. Clustering gene expression patterns. J. Comput. Biol. 6, 281-297 (1999).
15. Adams, J. C. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. Mol. Biol. Cell 8, 2345-2363 (1997).
16. Scott, G. & Liang, H. pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Exp Cell Res. 219, 197-203 (1995).
17. Jannji, B., Melchior, C., Guon, V., Vallar, L. & Kieffer, N. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-llinked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int. J. Cancer 83, 255-262 (1999).
18. Hieken, T. et al. Beta 1 integrin expression in malignant melanoma predicts occult lymph note metastases. Surgery 118, 669-673 (1995).
19. Van Belle, P. et al. Progression-related expression of beta3 integrin in melanomas and nevi. Hum. Pathol. 30, 562-567 (1999)
20. Woods, A., Longley, R., Tumova, S. & Couchman, J. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 374, 66-72 (2000).
21. Helige, C. et al. Interrelation of motility, cytoskeletal organization and gap junctional communication with invasiveness of melanocytic cells in vitro. Invasion Metastasis 17, 26-41 (1997).
22. Maung, K., Easty, DJ., Hill, S. & Bennett, D. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 18, 6824-6828 (1999).
23. Silletti, S., Paku, S. & Raz, A. Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization. Int. J. Cancer 76, 120-128 (1998.)
24. Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P. & Trent, J. Expression profiling using cDNA microarrays. Nature Genet. 21, 10-14, (1999).
25. Khan, J., Bittner, M., Chen, Y., Meltzer, P. & Trent, J. DNA Microarray technology: the anticipated impact on the study of human disease. Biochim. Biophys. Acta 1423, 17-28 (1999).
26. Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617 (1938).
27. Berens, M., Rief, M., Loo, M. & Giese, A. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin. Exp. Metastasis 12, 405-415 (1994).
28. Giese, A., Loo, M., Norman, S., Treasurywala, S. & Berens, M. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J. Cell Sci. 109, 2161-8 (1996).
29. Hendrix, M., Seftor, E., Seftor, R. & Fidler, I. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett. 38, 137-147 (1987).
30. Hendrix, M., Seftor, E., Chu, Y., Trevor, K. & Seftor, R. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525 (1996).